1. Home
  2. BCRX vs IMKTA Comparison

BCRX vs IMKTA Comparison

Compare BCRX & IMKTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCRX
  • IMKTA
  • Stock Information
  • Founded
  • BCRX 1986
  • IMKTA 1963
  • Country
  • BCRX United States
  • IMKTA United States
  • Employees
  • BCRX N/A
  • IMKTA N/A
  • Industry
  • BCRX Biotechnology: Biological Products (No Diagnostic Substances)
  • IMKTA Food Chains
  • Sector
  • BCRX Health Care
  • IMKTA Consumer Staples
  • Exchange
  • BCRX Nasdaq
  • IMKTA Nasdaq
  • Market Cap
  • BCRX 1.6B
  • IMKTA 1.3B
  • IPO Year
  • BCRX 1994
  • IMKTA N/A
  • Fundamental
  • Price
  • BCRX $7.49
  • IMKTA $68.33
  • Analyst Decision
  • BCRX Strong Buy
  • IMKTA
  • Analyst Count
  • BCRX 5
  • IMKTA 0
  • Target Price
  • BCRX $15.60
  • IMKTA N/A
  • AVG Volume (30 Days)
  • BCRX 1.7M
  • IMKTA 106.3K
  • Earning Date
  • BCRX 11-04-2024
  • IMKTA 02-06-2025
  • Dividend Yield
  • BCRX N/A
  • IMKTA 0.97%
  • EPS Growth
  • BCRX N/A
  • IMKTA N/A
  • EPS
  • BCRX N/A
  • IMKTA 8.40
  • Revenue
  • BCRX $412,579,000.00
  • IMKTA $5,827,075,484.00
  • Revenue This Year
  • BCRX $38.01
  • IMKTA N/A
  • Revenue Next Year
  • BCRX $19.04
  • IMKTA N/A
  • P/E Ratio
  • BCRX N/A
  • IMKTA $8.12
  • Revenue Growth
  • BCRX 29.92
  • IMKTA 1.17
  • 52 Week Low
  • BCRX $4.03
  • IMKTA $59.73
  • 52 Week High
  • BCRX $8.88
  • IMKTA $89.59
  • Technical
  • Relative Strength Index (RSI)
  • BCRX 48.08
  • IMKTA 41.76
  • Support Level
  • BCRX $7.55
  • IMKTA $68.83
  • Resistance Level
  • BCRX $8.07
  • IMKTA $72.22
  • Average True Range (ATR)
  • BCRX 0.33
  • IMKTA 1.85
  • MACD
  • BCRX 0.00
  • IMKTA -0.62
  • Stochastic Oscillator
  • BCRX 36.19
  • IMKTA 12.92

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

About IMKTA Ingles Markets Incorporated

Ingles Markets Inc is a U.S.-based company that is principally engaged in operating a supermarket chain. The company operates the business in the southeast United States, mainly in Georgia, North Carolina, South Carolina, and Tennessee, with a few stores in Virginia and Alabama as well. The company locates its stores majorly in suburban areas, small towns, and neighborhood areas. It offers a broad range of goods, including food products, pharmacies, health and beauty care products, and general merchandise. The retail business contributes the majority of the company's revenue. The company's real estate ownership of a material portion of total stores enables it to generate rental income.

Share on Social Networks: